Armata Pharmaceuticals, Inc. SEC filings ARMP
Armata Pharmaceuticals, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jan 27, 2004. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 23, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 22, 2025 | — |
| CORRESP | Letter to the SEC | Aug 20, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 15, 2025 | — |
| UPLOAD | Letter from the SEC | Nov 13, 2023 | — |
| CORRESP | Letter to the SEC | Nov 7, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 26, 2023 | — |
| EFFECT | Filing | Apr 6, 2023 | — |
| CORRESP | Letter to the SEC | Apr 5, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 17, 2023 | — |
| EFFECT | Filing | May 31, 2022 | — |
| CORRESP | Letter to the SEC | May 26, 2022 | — |
| UPLOAD | Letter from the SEC | May 19, 2022 | — |
| EFFECT | Filing | Apr 6, 2022 | — |
| CORRESP | Letter to the SEC | Apr 5, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 1, 2022 | — |
| EFFECT | Filing | May 20, 2021 | — |
| CORRESP | Letter to the SEC | May 18, 2021 | — |
| UPLOAD | Letter from the SEC | May 18, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 24, 2021 | — |
| CORRESP | Letter to the SEC | Feb 22, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 19, 2021 | — |
| EFFECT | Filing | Apr 8, 2020 | — |
| EFFECT | Filing | Apr 8, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2020 | — |
| CORRESP | Letter to the SEC | Apr 6, 2020 | — |
| CORRESP | Letter to the SEC | Apr 6, 2020 | — |
| RW | Filing | Jan 30, 2020 | — |
| POS EX | Filing | Oct 12, 2018 | — |
| EFFECT | Filing | Oct 11, 2018 | — |
| CORRESP | Letter to the SEC | Oct 9, 2018 | — |
| CORRESP | Letter to the SEC | Oct 9, 2018 | — |
| UPLOAD | Letter from the SEC | Aug 28, 2018 | — |
| CT ORDER | Filing | Jul 10, 2018 | — |
| RW | Filing | Jan 17, 2018 | — |
| EFFECT | Filing | May 4, 2017 | — |
| CORRESP | Letter to the SEC | May 4, 2017 | — |
| CORRESP | Letter to the SEC | May 4, 2017 | — |
| CORRESP | Letter to the SEC | May 4, 2017 | — |
| CORRESP | Letter to the SEC | May 4, 2017 | — |
| UPLOAD | Letter from the SEC | Apr 13, 2017 | — |
| CT ORDER | Filing | Mar 15, 2017 | — |
| POS EX | Filing | Nov 17, 2016 | — |
| EFFECT | Filing | Nov 16, 2016 | — |
| CORRESP | Letter to the SEC | Nov 10, 2016 | — |
| CORRESP | Letter to the SEC | Nov 10, 2016 | — |
| UPLOAD | Letter from the SEC | Sep 9, 2016 | — |
| EFFECT | Filing | May 13, 2016 | — |
| CORRESP | Letter to the SEC | May 11, 2016 | — |
| CT ORDER | Filing | May 11, 2016 | — |
| UPLOAD | Letter from the SEC | May 6, 2016 | — |
| CERTNYS | Auto-generated paper document | Aug 18, 2015 | — |
| 8-A12B | Filing | Aug 18, 2015 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2015 | — |
| CORRESP | Letter to the SEC | Jul 2, 2015 | — |
| UPLOAD | Letter from the SEC | Jul 1, 2015 | — |
| UPLOAD | Letter from the SEC | Jul 1, 2015 | — |
| PRER14A | Filing | Jun 24, 2015 | — |
| CORRESP | Letter to the SEC | Jun 24, 2015 | — |
| UPLOAD | Letter from the SEC | Jun 15, 2015 | — |
| UPLOAD | Letter from the SEC | May 26, 2015 | — |
| EFFECT | Filing | May 14, 2015 | — |
| CORRESP | Letter to the SEC | May 13, 2015 | — |
| CT ORDER | Filing | Apr 30, 2015 | — |
| UPLOAD | Letter from the SEC | Apr 24, 2015 | — |
| NT 10-K | Filing | Mar 31, 2015 | Dec 31, 2014 |
| D | Filing | Mar 30, 2015 | — |
| CT ORDER | Filing | Jan 13, 2015 | — |
| EFFECT | Filing | Dec 29, 2014 | — |
| CORRESP | Letter to the SEC | Dec 23, 2014 | — |
| UPLOAD | Letter from the SEC | Dec 19, 2014 | — |
| UPLOAD | Letter from the SEC | Nov 24, 2014 | — |
| CORRESP | Letter to the SEC | Nov 18, 2014 | — |
| 10-12G/A | Filing | Nov 17, 2014 | — |
| UPLOAD | Letter from the SEC | Nov 14, 2014 | — |
| NT 10-Q | Filing | Aug 15, 2014 | Jun 30, 2014 |
| CORRESP | Letter to the SEC | Aug 12, 2014 | — |
| CORRESP | Letter to the SEC | Jul 16, 2014 | — |
| UPLOAD | Letter from the SEC | Jun 23, 2014 | — |
| CORRESP | Letter to the SEC | Jun 10, 2014 | — |
| CORRESP | Letter to the SEC | May 22, 2014 | — |
| 10-12G/A | Form 10-12 g/a | May 22, 2014 | — |
| NT 10-Q | Filing | May 15, 2014 | Mar 31, 2014 |
| UPLOAD | Letter from the SEC | May 8, 2014 | — |
| 10-12G/A | Filing | Apr 15, 2014 | — |
| CORRESP | Letter to the SEC | Apr 15, 2014 | — |
| NT 10-K | Filing | Mar 31, 2014 | Dec 31, 2013 |
| CORRESP | Letter to the SEC | Mar 10, 2014 | — |
| UPLOAD | Letter from the SEC | Feb 25, 2014 | — |
| CORRESP | Letter to the SEC | Feb 4, 2014 | — |
| CORRESP | Letter to the SEC | Feb 4, 2014 | — |
| 10-12G/A | Form 10-12g/a | Feb 4, 2014 | — |
| UPLOAD | Letter from the SEC | Jan 30, 2014 | — |
| CORRESP | Letter to the SEC | Jan 27, 2014 | — |
| UPLOAD | Letter from the SEC | Jan 13, 2014 | — |
| D | Filing | Jan 2, 2014 | — |
| 10-12G | Form 10-12g | Dec 16, 2013 | — |
| D/A | Filing | Aug 8, 2013 | — |
| D/A | Filing | Jul 31, 2013 | — |
| D | Filing | Jul 10, 2013 | — |
| D | Filing | Feb 25, 2013 | — |
| 15-12G/A | Amendment no. 1 to form 15 | Mar 12, 2010 | — |
| 15-12G | Deregistration | Mar 8, 2010 | — |
| EFFECT | Filing | Mar 3, 2010 | — |
| EFFECT | Filing | Mar 3, 2010 | — |
| EFFECT | Filing | Mar 3, 2010 | — |
| EFFECT | Filing | Mar 3, 2010 | — |
| EFFECT | Filing | Mar 3, 2010 | — |
| 25 | Notification of removal from listing | Feb 24, 2010 | — |
| CT ORDER | Filing | Jan 7, 2010 | — |
| CT ORDER | Filing | Sep 21, 2009 | — |
| CT ORDER | Filing | Sep 21, 2009 | — |
| CT ORDER | Filing | Sep 21, 2009 | — |
| CT ORDER | Filing | Sep 21, 2009 | — |
| CT ORDER | Filing | Sep 21, 2009 | — |
| CT ORDER | Filing | Aug 12, 2009 | — |
| UPLOAD | Letter from the SEC | Mar 31, 2009 | — |
| CORRESP | Letter to the SEC | Mar 31, 2009 | — |
| UPLOAD | Letter from the SEC | Mar 30, 2009 | — |
| CT ORDER | Filing | Aug 7, 2008 | — |
| CT ORDER | Filing | Aug 7, 2008 | — |
| CORRESP | Letter to the SEC | Nov 13, 2007 | — |
| UPLOAD | Letter from the SEC | Nov 8, 2007 | — |
| EFFECT | Filing | Jul 30, 2007 | — |
| EFFECT | Filing | Feb 8, 2007 | — |
| CORRESP | Letter to the SEC | Feb 8, 2007 | — |
| CORRESP | Letter to the SEC | Feb 8, 2007 | — |
| CORRESP | Letter to the SEC | Feb 7, 2007 | — |
| UPLOAD | Letter from the SEC | Feb 2, 2007 | — |
| REGDEX | Auto-generated paper document | Nov 20, 2006 | — |
Showing 130 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ARMP (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- WA
- Headquarters
- Los Angeles, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 921114
- Former names
- AmpliPhi Biosciences Corp (until May 8, 2019); TARGETED GENETICS CORP /WA/ (until Feb 11, 2011)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.